Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma 论文

2018OncoTargets and Therapy引用 280
DOIPDF
Melanoma and MAPK PathwaysComputational Drug Discovery MethodsCytokine Signaling Pathways and Interactions
Computational Drug Discovery MethodsMelanoma and MAPK PathwaysCytokine Signaling Pathways and Interactions
相关技术:Computational Drug Discovery Methods
关系图谱

Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma · 相关事件

暂无数据